COHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS

FDA Premarket Approval P940011 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the additional indication for use for the treatment of microinvasive endobronchial nonsmall cell lung cancer in patients for whom surgery and radiotherapy are not indicated.

DeviceCOHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS
ApplicantLUMENIS, INC.
Date Received1997-02-14
Decision Date1998-01-09
PMAP940011
SupplementS001
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address LUMENIS, INC. 3959 West 1820 South salt Lake City, UT 84104

Supplemental Filings

Supplement NumberDateSupplement Type
P940011Original Filing
S003 1998-07-10 Normal 180 Day Track
S002 1998-03-25 Normal 180 Day Track
S001 1997-02-14 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.